Drugs & Medical Devices
Judge Dan Polster considers a recommended strategy for bring all locales into consolidated litigation.
Amgen’s drug patent upheld and Novartis’s copycat version is denied.
Three of the top pharmaceutical companies have entered agreements to pay the state of California nearly $70 million to settle allegations that they “delayed drugs to keep prices high” according to California Attorney General Xavier Becerra. Most of the funds will come from Teva Pharmaceuticals ($69 million) for paying to delay a generic for Provigil,
Novartis manipulated data to win approval for its spinal muscular atrophy treatment.
Connecticut is joining in on an investigation into JUUL’s marketingn efforts.
What do you know about Hepatitis C and its treatment? Being an informed patient is helpful to successful outcomes.
Cardinal Health, McKesson, and AmerisourceBergen have proposed paying $10 billion to settle all claims that they contributed to the opioid crisis. All three opioid distributors have been hit hard with claims that they did not do enough to flag and discontinue shipping large, suspicious orders of addictive drugs. The companies made the verbal proposal with
Opioid settlement needs to have more directon than the tobacco one, experts say.